Lipocalin 2 produces insulin resistance and can be upregulated by glucocorticoids in human adipose tissue
The adipokine lipocalin 2 is linked to obesity and metabolic disorders. However, its role in human adipose tissue glucose and lipid metabolism is not explored. Here we show that the synthetic glucocorticoid dexamethasone dose-dependently increased lipocalin 2 gene expression in subcutaneous and omen...
Saved in:
Published in: | Molecular and cellular endocrinology Vol. 427; pp. 124 - 132 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Ireland
Elsevier Ireland Ltd
15-05-2016
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The adipokine lipocalin 2 is linked to obesity and metabolic disorders. However, its role in human adipose tissue glucose and lipid metabolism is not explored. Here we show that the synthetic glucocorticoid dexamethasone dose-dependently increased lipocalin 2 gene expression in subcutaneous and omental adipose tissue from pre-menopausal females, while it had no effect in post-menopausal females or in males. Subcutaneous adipose tissue from both genders treated with recombinant human lipocalin 2 showed a reduction in protein levels of GLUT1 and GLUT4 and in glucose uptake in isolated adipocytes. In subcutaneous adipose tissue, lipocalin 2 increased IL-6 gene expression whereas expression of PPARγ and adiponectin was reduced. Our findings suggest that lipocalin 2 can contribute to insulin resistance in human adipose tissue. In pre-menopausal females, it may partly mediate adverse metabolic effects exerted by glucocorticoid excess.
•This study demonstrates a role of lipocalin 2 in human adipose tissue metabolism.•Dexamethasone induces lipocalin 2 gene expression in pre-menopausal females.•Stromal vascular cells are major contributors of lipocalin 2 expression.•Lipocalin 2 impairs basal and insulin-stimulated glucose uptake in adipocytes.•Lipocalin 2 reduces PPARγ and adiponectin expression. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0303-7207 1872-8057 1872-8057 |
DOI: | 10.1016/j.mce.2016.03.011 |